Yesterday, Dendreon Corp (DNDN) announced that the FDA has agreed to allow them to amend the trial design of its Provenge cancer vaccine. The change in the design will accelerate the expected timing of the final study results by about one year. According to Dendreon, the interim results of the impact study are still expected [...]
Last year 1.5 million Americans were diagnosed with cancer. Every year 560,000 Americans will die from the disease. Over the past five years federal funding has been flat for cancer research. The effect of flat funding has been devastating. The rate of medical inflation far outstrips the rate in the general economy. This means that [...]
Androgen blockades come in many different configurations. One of these configurations known as monotherapy, or ADT1, involves using only the drug Bicalutamide (Casodex). The most common androgen blockade (ADT2) involves using Bicalutamide along with an agonadotropin releasing hormone (GnRH) agonists (i.e. Lupron and Leuprolide). Some men also add a third drug (ADT3), Adovart or Proscar. [...]
Second and third opinions should be a standard part of your treatment plan. Whether you are newly diagnosed with advanced prostate cancer or you’re an old pro your care is not complete until you have had at least one set of additional eyes evaluate your situation. Physicians from the same practice or hospital tend to [...]
We all want to leave behind a legacy. No matter how rich or poor you are the best legacy we can gift our children and our community is our values. Through an ethical will we all can leave a true, personal legacy of our values and love. You can all write an ethical will that [...]